AbbVie Submits FDA Application for Etentamig in Relapsed or Refractory Multiple Myeloma

–  Etentamig is a second-generation BCMA-directed bispecific antibody T-cell engager with a clinical profile and dosing schedule that can pote...

October 29, 2026 | Thursday | News
Orphan Therapeutics Accelerator In-Licenses Gene Therapy for Rare Pediatric OTC Deficiency

OTXL-101, a promising therapy in development for a severe, rare pediatric metabolic condition, becomes the first pipeline program to be in-licensed by Or...

October 29, 2026 | Thursday | News
SEKISUI Diagnostics Launches 510(k)-Cleared COVID-19 and Flu A&B Combo Test

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&...

October 29, 2026 | Thursday | News
CellsBin Wins NCI SBIR Award to Advance Blood-Based Multiple Myeloma Test

CellsBin®, a biotechnology company pioneering Rare-Cell Biology™, announced that it has received a Direct-to-Phase II Small Business Innov...

October 29, 2026 | Thursday | News
Astellas Secures Option to License Audax’s DAX-044 Immuno-Oncology Candidate in US$285m Deal

Astellas Pharma Inc. [TSE: 4503, President and CEO: Naoki Okamura, "Astellas"] and Audax Biosciences Pty Ltd ("Audax")  announced that they have ent...

October 29, 2026 | Thursday | News
Kos Biotechnology Partners Invests in Golden Age Health to Expand Rare Disease Drug Access in Asia

Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President Kos Biotechnology Partners ("Kos"), a global ...

October 28, 2026 | Wednesday | News
Henlius Reports ASTRIDE Trial Results for Serplulimab in First-Line Small Cell Lung Cancer

ASTRIDE trial for first-line ES-SCLC demonstrated favorable median overall survival in serplulimab with chemotherapy versus atezo...

October 28, 2026 | Wednesday | News
Quotient Sciences and Acesion Pharma Collaborate on AI-Enhanced Formulation Development

  Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-base...

September 30, 2026 | Wednesday | News
Daiichi Sankyo and Merck Withdraw U.S. BLA for Ifinatamab Deruxtecan in Small Cell Lung Cancer

The Biologics License Application (BLA) seeking accelerated approval in the U.S. for Daiichi Sankyo (TSE: 4568) and Merck’s (NYSE: MRK), known as M...

September 28, 2026 | Monday | News
RefinedScience Expands Pancreatic Cancer Dataset With Multi-Institutional Sample Access

Marsico Pancreatic Cancer Initiative at CU Anschutz expands across institutions, pairing single-cell and spatial profiles with longitudinal outcomes fr...

September 28, 2026 | Monday | News
Pharming Seeks FDA Approval to Expand Joenja Use to Younger Children With APDS

If approved, Joenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or more Decision follows recent approval ...

September 28, 2026 | Monday | News
BioArctic’s Leqembi Begins Patient Treatment in Sweden Outside Clinical Study

 BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced  that Leqembi is now available at a private clinic in Sweden and that the first patie...

September 24, 2026 | Thursday | News
Elabscience Launches EasySort Mouse CD4 Nanobeads for Positive Cell Selection

Elabscience® Bionovation Inc. ("Elabscience®" or "the Company") launched EasySort™ Mouse CD4 Nanobeads on September 22, 2026, the Comp...

September 24, 2026 | Thursday | News
NanoImaging Services and Proteos Launch TrueCourse Biosciences to Integrate Drug Discovery Capabilities

NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have  announced the launch of TrueCourse Biosciences, an in...

September 24, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close